Search

Your search keyword '"Endoh, M"' showing total 1,260 results
Start Over Author "Endoh, M"
1,260 results on '"Endoh, M"'

110. Recent Surgical Strategies for Rectal Cancer.

Author

Morita, T., primary, Itoh, T., additional, Nakamura, F., additional, Suzuki, J., additional, Baba, T., additional, Nanmoku, K., additional, Yoshizaki, T., additional, Endoh, M., additional, Hakamada, K., additional, and Konn, M., additional

Published
1996
Full Text
View/download PDF

126. A Study on Postoperative Complications and the Treatment of Pelvic Exenteration with Combined Resection of Urinary Bladder and Sacrum for Colorectal Cancer.

Author

Okuyama, K., primary, Awano, T., additional, Matsubara, H., additional, Koide, Y., additional, Kinoshita, H., additional, Funami, Y., additional, Matsushita, K., additional, Nagashima, T., additional, Endoh, M., additional, Sakamoto, A., additional, Urashima, T., additional, and Isono, K., additional

Published
1993
Full Text
View/download PDF

142. Rheumatoid factors and glomerulonephritis

Author

MIYAZAKI, M, primary, ENDOH, M, additional, SUGA, T, additional, YANO, N, additional, KURAMOTO, T, additional, MATSUMOTO, Y, additional, EGUCHI, K, additional, YAGAME, M, additional, MIURA, M, additional, NOMOTO, Y, additional, and SAKAI, H, additional

Published
1990
Full Text
View/download PDF

149. Acquired storage-pool disorders occurring late after allogeneic bone marrow transplantation: partial activation of platelets in asymptomatic patients.

Author

Sakashita, C, Akiyama, H, Satoh, Y, Inoue, T, Ohashi, K, Mori, S, Sakamaki, H, Hiruma, K, Endoh, M, Akamatsu, N, and Tanoue, K

Abstract

Bone marrow transplantation (BMT) may be complicated by coagulation abnormalities. The present study evaluated whether platelets might be activated in patients who had undergone BMT without significant coagulopathy. The patients selected had received allogeneic BMTs a median of 39 months before the study (range, 11-124 months) and had not received cyclosporine, FK506 (tacrolimus), or other medication affecting cyclo-oxygenase for at least 3 months prior to the collection of blood samples. Furthermore, patients had platelet counts greater than 100 x 10(9) cells/L and normal serum creatinine levels. Twenty-five healthy volunteers acted as controls. Platelet aggregation studies and a mepacrine assay of platelets showed abnormal aggregation and decreased staining in some patients. The platelet storage-pool adenosine 5'-triphosphate (ATP) level in 15 patients after BMT was 0.45+/-0.24 micromol per 10(11) platelets, whereas the level in 18 controls was 1.03+/-0.36 micromol per 10(11) platelets (P = .00078). The total ATP levels of platelets in patients and controls were 4.33+/-1.14 and 5.63+/-1.51 micromol per 10(11) platelets, respectively (P = .016). With the exception of 1 patient, plasma levels of thrombomodulin and von Willebrand factor were all within the normal range. The average plasma level of 11-dehydrothromboxane B2 was significantly increased in 15 patients after BMT compared with controls, 20.6+/-8.2 and 10.3+/-1.2 pg/mL, respectively (P = .0004). These findings suggest a long-term process of platelet activation in patients after BMT and, following the cessation of cyclosporine, development of acquired storage-pool disorder of platelets. [ABSTRACT FROM AUTHOR]

Published
2001
Full Text
View/download PDF

150. PANCREATOBLASTOMA.

Author

Kohda, E., Iseki, M., Ikawa, H., Endoh, M., Yokoyama, J., Mukai, M., Hata, J., Yamazaki, H., Miyauchi, J., and Saeki, M.

Subjects
PANCREATIC diseases, TOMOGRAPHY, MAGNETIC resonance imaging, ULTRASONIC imaging
Abstract

AbstractPurpose: To describe the characteristics of pancreatoblastoma. Material and Methods: We studied 3 cases of pancretoblastoma and reviewed another 59 cases. Parameters analyzed were tumor site, hemorrhage, capsule formation, necrosis, vascularity, production of alpha-fetoprotein (AFP), cystic changes and calcification. Results: The diagnostic findings were as follows: pancreatic head origin (24/54, 44%), pancreatic body and tail origin (30/54, 56%), hemorrhage (16/17, 94%), capsule formation (24/26, 92%), necrosis (28/31, 90%), hypervascularity (10/14, 71%), production of AFP (19/28, 68%), cystic changes (11/16, 69%), and calcification (10/21, 48%). All neonatal cases demonstrated cystic changes. Three of them were patients with Beckwith-Wiedmann syndrome. The incidence of capsule formation and calcification was not related to the origin of the tumor. Conclusion: The most common features of pancreatoblastoma are hemorrhage, capsule formation and necrosis. [ABSTRACT FROM AUTHOR]

Published
2000
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results